"There was a lot of celebration," said 82-year-old Rolfe Johnson.
Johnson recently tried Aduhelm at UTHealth. He was diagnosed with Alzheimer's five years ago and spoke with ABC13 about trying the new treatment.
"I might have been a little frightened, or a little apprehensive, except that I had already been through two trials of other drugs in years past, and so far, as I could tell, they either postponed or held off the effects of my disease or at least were not harmful," he said.
The Food and Drug Administration (FDA) recently approved the new treatment and said it's the first novel therapy approved for Alzheimer's since 2003.
READ MORE: In controversial decision, FDA approves first new Alzheimer's disease drug in nearly 20 years
"It's the first one that's worked, which is really valuable," said Johnson's doctor at UTHealth Paul Schulz. "It really gives us a lot of hope. It basically changed the rate of decline about 20% to 40% on different parameters. That's a lot. That means people essentially have a couple of extra years of doing better."
UTHealth said Memorial Hermann afforded Johnson six months' worth of treatment.
He and his wife of more than 60 years, Carol, are hopeful.
"He has really stabilized from where he was when he was first diagnosed and that's a lifestyle we can live with," she said.
READ ALSO: 10-year-old Fremont-native walks to help end Alzheimer's for his grandfather
For updates on this story, follow ABC13 reporter TJ Parker on Facebook, Twitter and Instagram.